Pessaries (mechanical devices) for pelvic organ prolapse in women

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 2, 2013, Pages

  Bugge, Carol ^a   Adams, Elisabeth J ^b   Gopinath, Deepa ^c   Reid, Fiona ^d  

^a UNIVERSITY OF STIRLING   (United Kingdom)

^b LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EFFECTIVENESS; FOLLOW UP; HUMAN; PELVIC ORGAN PROLAPSE; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; BLADDER DISEASE; FEMALE; RECTUM PROLAPSE; URETHRA DISEASE; UTERUS PROLAPSE; VAGINA PESSARY;

FEMALE; HUMANS; PELVIC ORGAN PROLAPSE; PESSARIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL PROLAPSE; URETHRAL DISEASES; URINARY BLADDER DISEASES; UTERINE PROLAPSE;

EID: 84875525678     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004010.pub3     Document Type: Review

References (37)

1. Cundiff GN, Amundsen CL, Bent AE, Coates KW, Schaffer JI, Strohbehn K, et al.The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. American Journal of Obstetrics and Gynecology 2007;196(4):405.e1-8. [: SR-INCONT23081; PUBMED: 17403437]
2. Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. American Journal of Obstetrics and Gynecology 2001;185(6):1388-95.
3. Basu M, Wise B, Duckett J. A qualitative study of women's preferences for treatment of pelvic floor disorders. BJOG 2011;118:338-44.
4. Bump RC, Mattiasson A, Bo K, Brubaker LP, Delancey JOL, Klarskov P, et al.The standardisation of terminology of female pelvic organ prolapse and pelvic floor dysfunction. American Journal of Obstetrics and Gynecology 1996;175(1):10-7.
5. Bump R, Norton P. Epidemiology and natural history of pelvic floor dysfunction. Obstetrics and Gynecology Clinics of North America 1998;25(4):723-46.
6. Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Risk factors associated with an unsuccessful pessary fitting trial in women with pelvic organ prolapse. American Journal of Obstetrics and Gynecology 2004;190(2):345-50.
7. Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. American Journal of Obstetrics and Gynecology 2004;190(4):1025-9.
8. Clemons JL, Aguilar VC, Sokol ER, Jackson ND, Myers DL. Patient characteristics that are associated with continued pessary use versus surgery after 1 year. American Journal of Obstetrics and Gynecology 2004;191(1):159-64.
9. Cundiff GW, Weidner AC, Visco AG, Bump RC, Addison WA. A survey of pessary use by members of the American Urogynecologic Society. American Journal of Obstetrics and Gynecology 2000;95(6):931-5.
10. Dietz HP. The aetiology of prolapse. International Urogynecology Journal 2008;19:1323-9.
11. Gorti M, Hundelist G, Simons A. Evaluation of vaginal pessary management: A UK-based survey. Journal of Obstetrics and Gynaecology 2009;29(2):129-31.
12. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology 2011;64(4):380-2.
13. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al.GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 2011;64(12):1311-6.
14. Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al.GRADE guidelines: 12. Preparing Summary of Findings tables-binary outcomes. Journal of Clinical Epidemiology 2013;66(2):158-72.
15. Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, et al.GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles-continuous outcomes. Journal of Clinical Epidemiology 2013;66(2):173-83.
16. Hagen S, Glazener C, Sinclair L, Stark D, Bugge C. Psychometric properties of the Pelvic Organ Prolapse Symptom Score (POP-SS). British Journal of Obstetrics and Gynaecology 2009;116(1):25-31.
17. Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD003882.pub4]
18. Handa VL, Jones M. Do pessaries prevent the progression of pelvic organ prolapse?. International Urogynecological Journal 2002;13(6):349-51.
19. Hanson LM, Schultz J, Flood CG, Cooley B, Tam F. Vaginal pessaries in managing women with pelvic organ prolapse and urinary incontinence:patient characteristics and factors contributing to success. International Urogynecological Journal 2006;17:155-9.
20. Hay-Smith J, Berghmans B, Burgio K, Dumoulin C, Hagen S, Moore K, Nygaard I. Adult Conservative Management. Incontinence, Fourth International Consultation on Incontinence. Plymouth, UK: Health Publication Ltd, 2009.
21. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
22. Ismail SI, Bain C, Hagen S. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD007063.pub2]
23. Kapoor DS, Thakar R, Sultan AH, Oliver R. Conservative versus surgical management of prolapse: what dictates patient choice?. International Urogynecology Journal and Pelvic Floor Dysfunction 2009;20(10):1157-61.
24. Lipp A, Shaw C, Glavind K. Mechanical devices for urinary incontinence in women. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD001756.pub5]
25. Lone F, Thakar R, Sultan AH, Karamalis G. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse. International Journal of Gynaecology and Obstetrics 2011;114(1):56-9.
26. Lowder JL, Ghetti C, Nikolajski C, Oliphant SS, Zyczynski HM. Body image perceptions in women with pelvic organ prolapse: a qualitative study. American Journal of Obstetrics and Gynecology 2011;204(441):e1-5.
27. MacLennan AH, Taylor AW, Wilson DH, Wilson D. The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. British Journal of Obstetrics and Gynaecology 2000;107(12):1460-70. [MEDLINE: 21029149]
28. Maher C, Feiner B, Baessler K, Glazener CMA. Surgical management of pelvic organ prolapse in women. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD004014.pub4]
29. Manchana T, Bunyavejchevin S. Impact on quality of life after ring pessary use for pelvic organ prolapse. International Urogynecological Journal 2012;23(7):873-7.
30. Oliver R, Thakar R, Sultan AH. The history and usage of the vaginal pessary: a review. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2011;156:125-30.
31. Poma PA. Nonsurgical management of genital prolapse. A review and recommendations for clinical practice. Journal of Reproductive Medicine 2000;45(10):789-97. [MEDLINE: 20529405]
32. Pott-Grinstein E, Newcomer JR. Gynecologists' patterns of prescribing pessaries. Journal of Reproductive Medicine 2001;46(3):205-8. [MEDLINE: 21200525]
33. Samuelsson EC, Victor FTA, Tibblin G, Svardsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. American Journal of Obstetrics and Gynecology 1999;180(2):299-305.
34. Sloan JA. Cella D, Hays RD. Clinical significance of patient-reported questionnaire data: another step towards consensus. Journal of Clinical Epidemiology 2005;58:1217-9.
35. Swift SE. The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. American Journal of Obstetrics and Gynecology 2000;183(2):277-85.
36. Ware JE. Measuring patients' views: the optimum outcome measure. SF36: a valid, reliable assessment of health from the patient's point of view. British Medical Journal 1993;306(6890):1429-30.
37. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983;67(6):361-70.